<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>207(4)</volume><submitter>Bashy B</submitter><journal>British journal of haematology</journal><pagination>1659-1663</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12512062</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Differences in adverse events between manuscript and drug labels for myeloma T-cell-redirecting therapies.</pubmed_title><pmcid>PMC12512062</pmcid><pubmed_authors>Bashy B</pubmed_authors><pubmed_authors>Steensma D</pubmed_authors><pubmed_authors>Van Oekelen O</pubmed_authors><pubmed_authors>Shah D</pubmed_authors><pubmed_authors>Chakraborty R</pubmed_authors><pubmed_authors>Mohyuddin GR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Differences in adverse events between manuscript and drug labels for myeloma T-cell-redirecting therapies.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-04T07:04:31.559Z</modification><creation>2026-05-06T03:13:05.7Z</creation></dates><accession>S-EPMC12512062</accession><cross_references><pubmed>40923801</pubmed><doi>10.1111/bjh.70042</doi></cross_references></HashMap>